FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891782651> ?p ?o ?g. }

• W2891782651 endingPage "4897" @default.
• W2891782651 startingPage "4884" @default.
• W2891782651 abstract "Efficient drug accumulation in tumor is essential for chemotherapy. We developed redox-responsive diselenide-based high-loading prodrug nanoparticles (NPs) for targeted triple negative breast cancer (TNBC) treatment. Method: Redox-responsive diselenide bond (Se-Se) containing dimeric prodrug (PTXD-Se) was synthesized and co-precipitated with TNBC-targeting amphiphilic copolymers to form ultra-stable NPs (uPA-PTXD NPs). The drug loading capacity and redox-responsive drug release behavior were studied. TNBC targeting effect and anti-tumor effect were also evaluated in vitro and in vivo.Results: On-demand designed paclitaxel dimeric prodrug could co-precipitate with amphiphilic copolymers to form ultra-stable uPA-PTXD NPs with high drug loading capacity. Diselenide bond (Se-Se) in uPA-PTXD NPs could be selectively cleaved by abnormally high reduced potential in tumor microenvironment, releasing prototype drug, thus contributing to improved anti-cancer efficacy. Endowed with TNBC-targeting ligand uPA peptide, uPA-PTXD NPs exhibited reduced systemic toxicity and enhanced drug accumulation in TNBC lesions, thus showed significant anti-tumor efficacy both in vitro and in vivo. Conclusion: The comprehensive advantage of high drug loading, redox-controlled drug release and targeted tumor accumulation suggests uPA-PTXD NPs as a highly promising strategy for effective TNBC treatment." @default.
• W2891782651 created "2018-09-27" @default.
• W2891782651 creator A5003753200 @default.
• W2891782651 creator A5010710133 @default.
• W2891782651 creator A5010902410 @default.
• W2891782651 creator A5011051920 @default.
• W2891782651 creator A5011738757 @default.
• W2891782651 creator A5028289642 @default.
• W2891782651 creator A5030370802 @default.
• W2891782651 creator A5047750943 @default.
• W2891782651 creator A5058555426 @default.
• W2891782651 creator A5063815177 @default.
• W2891782651 creator A5066081927 @default.
• W2891782651 creator A5068814187 @default.
• W2891782651 creator A5071773009 @default.
• W2891782651 creator A5076461726 @default.
• W2891782651 date "2018-01-01" @default.
• W2891782651 modified "2023-10-16" @default.
• W2891782651 title "Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy" @default.
• W2891782651 cites W1976041621 @default.
• W2891782651 cites W1985498995 @default.
• W2891782651 cites W1997151511 @default.
• W2891782651 cites W2005517353 @default.
• W2891782651 cites W2006434892 @default.
• W2891782651 cites W2008294808 @default.
• W2891782651 cites W2023271753 @default.
• W2891782651 cites W2038720439 @default.
• W2891782651 cites W2057161502 @default.
• W2891782651 cites W2073188220 @default.
• W2891782651 cites W2111705896 @default.
• W2891782651 cites W2113737449 @default.
• W2891782651 cites W2123617256 @default.
• W2891782651 cites W2141122261 @default.
• W2891782651 cites W2153771870 @default.
• W2891782651 cites W2188402991 @default.
• W2891782651 cites W2279867722 @default.
• W2891782651 cites W2326532951 @default.
• W2891782651 cites W2327770163 @default.
• W2891782651 cites W2327890634 @default.
• W2891782651 cites W2328082795 @default.
• W2891782651 cites W2328558799 @default.
• W2891782651 cites W2331088496 @default.
• W2891782651 cites W2340338369 @default.
• W2891782651 cites W2511187670 @default.
• W2891782651 cites W2515349081 @default.
• W2891782651 cites W2538211775 @default.
• W2891782651 cites W2580784198 @default.
• W2891782651 cites W2592478616 @default.
• W2891782651 cites W2746923993 @default.
• W2891782651 cites W2752306846 @default.
• W2891782651 cites W2762235809 @default.
• W2891782651 cites W2766298110 @default.
• W2891782651 cites W2767878232 @default.
• W2891782651 cites W2776396536 @default.
• W2891782651 cites W2783404219 @default.
• W2891782651 cites W2785369048 @default.
• W2891782651 cites W2792429578 @default.
• W2891782651 cites W2793195158 @default.
• W2891782651 cites W53566393 @default.
• W2891782651 doi "https://doi.org/10.7150/thno.27581" @default.
• W2891782651 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6217054" @default.
• W2891782651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30429875" @default.
• W2891782651 hasPublicationYear "2018" @default.
• W2891782651 type Work @default.
• W2891782651 sameAs 2891782651 @default.
• W2891782651 citedByCount "31" @default.
• W2891782651 countsByYear W28917826512018 @default.
• W2891782651 countsByYear W28917826512019 @default.
• W2891782651 countsByYear W28917826512020 @default.
• W2891782651 countsByYear W28917826512021 @default.
• W2891782651 countsByYear W28917826512022 @default.
• W2891782651 countsByYear W28917826512023 @default.
• W2891782651 crossrefType "journal-article" @default.
• W2891782651 hasAuthorship W2891782651A5003753200 @default.
• W2891782651 hasAuthorship W2891782651A5010710133 @default.
• W2891782651 hasAuthorship W2891782651A5010902410 @default.
• W2891782651 hasAuthorship W2891782651A5011051920 @default.
• W2891782651 hasAuthorship W2891782651A5011738757 @default.
• W2891782651 hasAuthorship W2891782651A5028289642 @default.
• W2891782651 hasAuthorship W2891782651A5030370802 @default.
• W2891782651 hasAuthorship W2891782651A5047750943 @default.
• W2891782651 hasAuthorship W2891782651A5058555426 @default.
• W2891782651 hasAuthorship W2891782651A5063815177 @default.
• W2891782651 hasAuthorship W2891782651A5066081927 @default.
• W2891782651 hasAuthorship W2891782651A5068814187 @default.
• W2891782651 hasAuthorship W2891782651A5071773009 @default.
• W2891782651 hasAuthorship W2891782651A5076461726 @default.
• W2891782651 hasBestOaLocation W28917826511 @default.
• W2891782651 hasConcept C108215921 @default.
• W2891782651 hasConcept C121608353 @default.
• W2891782651 hasConcept C126322002 @default.
• W2891782651 hasConcept C150903083 @default.
• W2891782651 hasConcept C15920480 @default.
• W2891782651 hasConcept C178790620 @default.
• W2891782651 hasConcept C185592680 @default.
• W2891782651 hasConcept C202751555 @default.
• W2891782651 hasConcept C207001950 @default.
• W2891782651 hasConcept C2776694085 @default.

• next